No deals were found in the last 365 days.
No deals were found in the last 365 days.
| Notifier | Holding | Value* |
|---|---|---|
| Carolyn Cross | 156,314,029 | £15,240,618 |
| Nicolas Loebel | 3,538,991 | £345,052 |
| Junaid Bajwa | 1,193,697 | £116,386 |
| Jean Duvall | 1,163,529 | £113,444 |
| Jean Charest | 353,356 | £34,452 |
| Notifier** | Holding | Value* |
|---|---|---|
| Carolyn Cross | 120,161,319 | £11,715,729 |
| M&G Plc | 74,268,775 | £7,241,206 |
| hInsight-NX, LLC | 42,272,654 | £4,121,584 |
| Robert Cross | 37,772,652 | £3,682,834 |
| Albemarle Life Sciences Fund | 15,105,882 | £1,472,824 |
| CRUX Asset Management | 9,298,090 | £906,564 |
| Chelverton Asset Management | 7,957,311 | £775,838 |
| Currency | UK Pounds |
| Share Price | 9.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 15.00p |
| 52 Week Low | 8.00p |
| Volume | 0 |
| Shares Issued | 561.22m |
| Market Cap | £54.72m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 0 @ 0.000p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research